title: Ablative approach for primary liver cancer: Shanghai experience.
abstract: This article summarizes the results of 2018 patients receiving surgical treatment for pathologically proven primary liver cancer (PLC). Special references are made to the role of cryosurgery and cytoreduction for unresectable PLC.
authors.affiliation: Liver Cancer Institute, Shanghai Medical University, Shanghai, China.
authors.forename: X D
authors.initials: XD
authors.lastname: Zhou
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Tang
authors.forename: Y Q
authors.initials: YQ
authors.lastname: Yu
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D016461:Chemoembolization, Therapeutic; D002681:China; D003131:Combined Modality Therapy; D003452:Cryosurgery / Q000379:methods; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D016499:Radioimmunotherapy